Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Our key focus therapeutic areas are: • Endocrinology • Dermatology • Anaesthesia and analgesia • Ophthalmology • Cardiovascular disease • Equine locomotion • Food producing animal antimicrobials • And pet diets

Employee Rating

4.5More
TypePublic
HQLostock Gralam, GB
Founded1997
Size (employees)1,338 (est)+3%
Websitedechra.com
Dechra Pharmaceuticals was founded in 1997 and is headquartered in Lostock Gralam, GB
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Dechra Pharmaceuticals Office Locations

Dechra Pharmaceuticals has offices in Lostock Gralam, Skipton, Hadnall, Warszawa and in 12 other locations
Lostock Gralam, GB (HQ)
24 Cheshire Avenue Cheshire Business Park
Hadnall, GB
Sansaw Business Park
Skipton, GB
Snaygill Industrial Estate, Keighley Road
Dornbirn, AT
Hintere Achmühlerstraße 1A
Pointe-Claire, CA
1 Holiday Avenue, East Tower Suite 345
Uldum, DK
Mekuvej 9
Show all (16)
Report incorrect company information

Dechra Pharmaceuticals Financials and Metrics

Dechra Pharmaceuticals Revenue

Embed Graph
View revenue for all periods
Dechra Pharmaceuticals's revenue was reported to be £407.10 m in FY, 2018
GBP

Revenue (FY, 2018)

407.1m

Gross profit (FY, 2018)

222.4m

Gross profit margin (FY, 2018), %

54.6%

Net income (FY, 2018)

36.1m

EBITDA (FY, 2018)

95.5m

EBIT (FY, 2018)

34.1m

Cash (30-Jun-2018)

79.7m

EV

1.8b
GBPFY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

137.2m145.9m145.5m156.4m170.2m179.3m186.8m208.2m232.5m253.8m189.2m193.6m203.5m247.6m359.3m407.1m

Revenue growth, %

2%5%22%

Cost of goods sold

123.8m131.4m128.6m137.2m149.7m156.3m161.4m178.5m199.2m217.0m88.5m85.9m87.3m115.1m167.6m184.7m

Gross profit

13.4m14.5m16.9m19.2m20.5m23.0m25.4m29.7m33.3m36.9m100.7m107.7m116.1m132.4m191.7m222.4m
GBPFY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

4.2m4.7m9.2m4.0m13.9m19.7m17.2m32.8m26.8m45.9m39.1m61.2m79.7m

Accounts Receivable

16.6m18.7m20.7m23.2m24.6m26.8m31.3m31.8m33.5m34.0m25.3m28.3m27.7m59.2m59.7m76.0m

Inventories

9.3m11.7m16.2m16.5m19.3m17.3m17.0m20.4m22.0m25.7m29.2m29.7m31.7m54.4m56.5m86.6m

Current Assets

31.3m36.0m47.9m44.6m45.1m45.3m49.9m68.0m77.0m79.1m179.5m86.3m108.6m162.4m185.0m247.9m
GBPFY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

9.0k171.0k1.4m3.0m5.1m3.8m5.1m6.3m7.6m8.8m10.9m19.4m19.5m12.5m26.1m36.1m

Cash From Operating Activities

6.4m5.4m12.0m3.5m6.4m6.5m10.6m13.2m9.5m9.2m36.9m11.5m41.0m43.6m77.4m64.0m

Dividends Paid

1.9m2.1m2.1m2.4m2.7m2.8m3.6m11.2m12.6m13.9m15.3m17.7m400.0k

Cash From Financing Activities

39.9m(1.4m)(2.5m)2.7m(765.0k)(3.4m)(2.6m)11.8m(2.9m)(6.7m)(18.3m)(92.1m)(14.8m)125.3m1.6m193.8m
GBPY, 2018

EV/EBITDA

19.2 x

EV/EBIT

53.7 x

EV/CFO

28.6 x

Financial Leverage

2 x
Show all financial metrics
Report incorrect company information

Dechra Pharmaceuticals Online and Social Media Presence

Embed Graph
Report incorrect company information

Dechra Pharmaceuticals News and Updates

Pet Oral Care Market by Key Manufacturers (Allaccem, Inc., Ceva Sante Animale S.A., Colgate-Palmolive Company, Dechra Pharmaceuticals Plc. ) Forecast to 2025

ReportsWeb.com has announced the addition of the “Global Pet Oral Care Market Size Status and Forecast 2025” The report detailed insights about the aspects responsible for augmenting as well as restraining market growth. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information

Dechra Pharmaceuticals Company Life and Culture

Report incorrect company information

Dechra Pharmaceuticals Frequently Asked Questions

  • When was Dechra Pharmaceuticals founded?

    Dechra Pharmaceuticals was founded in 1997.

  • How many employees does Dechra Pharmaceuticals have?

    Dechra Pharmaceuticals has 1,338 employees.

  • What is Dechra Pharmaceuticals revenue?

    Latest Dechra Pharmaceuticals annual revenue is £407.1 m.

  • What is Dechra Pharmaceuticals revenue per employee?

    Latest Dechra Pharmaceuticals revenue per employee is £304.3 k.

  • Who are Dechra Pharmaceuticals competitors?

    Competitors of Dechra Pharmaceuticals include Biogen, Otonomy and Pfizer.

  • Where is Dechra Pharmaceuticals headquarters?

    Dechra Pharmaceuticals headquarters is located at 24 Cheshire Avenue Cheshire Business Park, Lostock Gralam.

  • Where are Dechra Pharmaceuticals offices?

    Dechra Pharmaceuticals has offices in Lostock Gralam, Skipton, Hadnall, Warszawa and in 12 other locations.

  • How many offices does Dechra Pharmaceuticals have?

    Dechra Pharmaceuticals has 16 offices.